Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis

Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis

The paper presents a detailed algorithm for the treatment and follow-up of patients with recurrent multiple sclerosis and primary progressive multiple sclerosis in the use of ocrelizumab.

Saved in:

Bibliographic Details
Main Authors:	A. N. Boyko, M. V. Davydovskaya, N. V. Khachanova, M. N. Zakharova, N. N. Spirin, E. V. Popova, V. M. Alifirova, Ya. V. Vlasov, S. A. Sivertseva, F. A. Khabirov, M. V. Shumilina, E. P. Evdoshenko
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2019-11-01
Series:	Неврология, нейропсихиатрия, психосоматика
Subjects:	ocrelizumab multiple sclerosis recurrent multiple sclerosis primary progressive multiple sclerosis monoclonal antibody
Online Access:	https://nnp.ima-press.net/nnp/article/view/1168
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet

https://nnp.ima-press.net/nnp/article/view/1168